Agilent Picks Up Halo Genomics and BioSystem Development
Published: Monday, December 05, 2011 Last Updated: Monday, December 05, 2011
The technologies company is expanding its life sciences business through the acquisition. Halo Genomics provides sample preparation technology for next-generation DNA sequencing, and BioSystem Development develops and manufactures sample prep solutions for drug R&D.
Full access to this article is for registered users only. Registration is free-of-charge and allows access to all content on our web communities.
Already registered? Then please log in at the top of the page.